New Agents and Approaches to Treatment in Niemann-Pick Type C Disease

Publisher： Bentham Science Publishers

E-ISSN： 1873-4316|12|6|897-901

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.12, Iss.6, 2011-06, pp. : 897-901

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Collaborative Development of 2-Hydroxypropyl-&bgr;-Cyclodextrin for the Treatment of Niemann-Pick Type C1 Disease

By  

Current Topics in Medicinal Chemistry, Vol. 14, Iss. 3, 2014-02 ,pp. : 330-339

Bentham Science Publishers

Access to resources Recommend Favorite

Modulation of Arachidonic Acid Metabolism in Niemann-Pick Disease Type C Cells

By Nakamura Hiroyuki  

Current Psychopharmacology, Vol. 2, Iss. 1, 2013-02 ,pp. : 58-65

Bentham Science Publishers

Access to resources Recommend Favorite

Modulation of Arachidonic Acid Metabolism in Niemann-Pick Disease Type C Cells

By  

Current Psychopharmacology, Vol. 2, Iss. 1, 2013-02 ,pp. : 58-65

Bentham Science Publishers

Access to resources Recommend Favorite

Neurodegeneration in Niemann-Pick Type C Disease and Huntington's Disease: Impact of Defects in Membrane Trafficking

By  

Current Drug Targets, Vol. 10, Iss. 7, 2009-07 ,pp. : 653-665

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacological Activation of LXRs Decreases Amyloid-β Levels in Niemann-Pick Type C Model Cells

By  

Current Pharmaceutical Biotechnology, Vol. 14, Iss. 6, 2013-07 ,pp. : 582-593

Bentham Science Publishers

Access to resources Recommend Favorite